Moleculin Biotech Income Statement (2016-2025) | MBRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating items
Research & Development (Quarter)	4.11M	3.04M	4.09M	3.18M	4.62M	4.20M	5.96M	4.18M	5.69M	3.89M	3.28M	6.63M	4.25M	4.09M	4.93M	4.46M	3.44M	3.60M	3.74M	5.12M
Selling, General & Administrative (Quarter)	1.94M	2.43M	2.02M	1.99M	2.42M	3.20M	3.09M	2.84M	2.64M	2.49M	2.63M	2.25M	2.39M	2.06M	2.17M	2.16M	2.48M	2.09M	2.15M	2.41M
Other Operating Expenses (Quarter)	0.04M	0.04M	0.04M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.04M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.02M	0.01M
Operating Expenses (Quarter)	6.09M	5.52M	6.16M	5.21M	7.07M	7.43M	9.08M	7.05M	8.35M	6.41M	5.95M	8.92M	6.68M	6.18M	7.13M	6.64M	5.94M	5.72M	5.91M	7.53M
Operating Income (Quarter)	-6.09M	-5.52M	-6.16M	-5.21M	-7.07M	-7.43M	-9.08M	-7.05M	-8.35M	-6.41M	-5.95M	-8.92M	-6.68M	-6.18M	-7.13M	-6.64M	-5.94M	-5.72M	-5.91M	-7.53M
EBIT (Quarter)	-6.09M	-5.52M	-6.16M	-5.21M	-7.07M	-7.43M	-9.08M	-7.05M	-8.35M	-6.41M	-5.95M	-8.92M	-6.68M	-6.18M	-7.13M	-6.64M	-5.94M	-5.72M	-5.91M	-7.53M
Non-operating items
Interest & Investment Income (Quarter)					0.04M	0.04M	0.03M	0.13M	0.39M	0.39M	0.32M	0.26M	0.24M	0.16M	0.10M	0.05M	0.03M	0.03M	0.04M	0.01M
Other Non Operating Income (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.00M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.02M	-0.05M
Non Operating Income (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.00M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.02M	-0.05M
Net income details
EBT (Quarter)	-6.09M	-5.52M	-6.16M	-24.03M	-7.03M	-7.39M	-9.05M	-32.62M	-7.96M	-6.02M	-5.62M	-40.97M	-6.44M	-6.03M	-7.03M	-6.60M	-5.91M	-5.69M	-5.87M	-7.52M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-4.45M	-4.24M	-4.38M	-2.80M	-6.87M	-6.78M	-8.61M	-6.77M	-7.92M	-5.98M	-5.61M	-10.27M	-6.42M	-6.01M	-7.02M	-6.58M	-5.90M	-17.81M	-25.40M	15.55M
Income from Continuing Operations (Quarter)	-6.09M	-5.52M	-6.16M	-24.03M	-7.03M	-7.39M	-9.05M	-32.62M	-7.96M	-6.02M	-5.62M	-40.97M	-6.44M	-6.03M	-7.03M	-6.60M	-5.91M	-5.69M	-5.87M	-7.52M
Consolidated Net Income (Quarter)	-6.09M	-5.52M	-6.16M	-24.03M	-7.03M	-7.39M	-9.05M	-32.62M	-7.96M	-6.02M	-5.62M	-40.97M	-6.44M	-6.03M	-7.03M	-6.60M	-5.91M	-5.69M	-5.87M	-7.52M
Income towards Parent Company (Quarter)	-6.09M	-5.52M	-6.16M	-24.03M	-7.03M	-7.39M	-9.05M	-32.62M	-7.96M	-6.02M	-5.62M	-40.97M	-6.44M	-6.03M	-7.03M	-6.60M	-5.91M	-5.69M	-5.87M	-7.52M
Net Income towards Common Stockholders (Quarter)	-6.09M	-5.52M	-6.16M	-24.03M	-7.03M	-7.39M	-9.05M	-32.62M	-7.96M	-6.02M	-5.62M	-40.97M	-6.44M	-6.03M	-7.03M	-6.60M	-5.91M	-5.69M	-5.87M	-7.52M
Additional items
EPS (Basic) (Quarter)	-0.20	-0.15	-0.15	-0.09	-0.24	-0.24	-0.30	-14.44	-4.13	-3.02	-2.82	-5.13	-2.61	-2.37	-1.89	-182.45	-0.63	-1.15	-0.68	-26.06
Shares Outstanding (Weighted Average) (Quarter)	2.72M	25.15M	2.72M	26.88M	2.66M	0.45M	2.66M	0.22M	1.92M	0.80M	0.90M	1.98M	1.07M	0.06M	2.91M	0.14M	0.00M	67.77M	20.83M	7.60M
EBITDA (Quarter)	-4.45M	-4.25M	-4.39M	-2.82M	-6.86M	-6.81M	-8.63M	-6.76M	-7.92M	-5.98M	-5.62M	-10.28M	-4.98M	-4.31M	-7.01M	-6.63M	-6.43M	-7.64M	-25.41M	15.61M
Interest Expenses (Quarter)				18.82M				25.70M				32.31M
Shares Outstanding (Quarter)	28.44M	0.00M	28.58M	1.91M	28.58M	28.61M	28.63M	1.91M	1.97M	1.99M	1.99M	0.09M	2.31M	2.56M	3.00M	0.14M	14.13M	30.21M	49.50M	3.20M
Tax Rate (Quarter)

Research Tools

Moleculin Biotech Income Statement (2016-2025) | MBRX

Create an account

Sign In

Reset Password